HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The bystander effect in experimental systems and compatibility with radon-induced lung cancer in humans.

Abstract
Bystander effects following exposure to alpha-particles have been observed in C3H 10T1/2 cells and in other experimental systems, and imply that linearly extrapolating low-dose risks from high-dose data might materially underestimate risk. The ratio of lung cancer risk among persons exposed to low and high doses of radon daughters is 2.4-4.0, with an upper 95% confidence limit (CL) of about 14. Assuming that the bystander effect observed in the C3H 10T 1/2 data applies to human lung cells in vivo, the epidemiological data imply that the number of neighbouring cells that can contribute to the bystander effect is between 0 and 1, with an upper 95% CL of about 7. As a consequence, the bystander effect observed in the C3H 10T1/2 system probably does not play a large part in the process of radon-induced lung carcinogenesis in humans. Other experimental data relating to the bystander effect after alpha-particle exposure are surveyed; some of these data are more compatible with the epidemiological data.
AuthorsM P Little, R Wakeford
JournalJournal of radiological protection : official journal of the Society for Radiological Protection (J Radiol Prot) Vol. 22 Issue 3A Pg. A27-31 (Sep 2002) ISSN: 0952-4746 [Print] England
PMID12400943 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Air Pollutants
  • Air Pollutants, Occupational
  • Air Pollutants, Radioactive
  • Radon
Topics
  • Air Pollutants (adverse effects)
  • Air Pollutants, Occupational (adverse effects)
  • Air Pollutants, Radioactive (adverse effects)
  • Animals
  • Bystander Effect
  • Cell Line, Transformed
  • Cell Transformation, Neoplastic (radiation effects)
  • Humans
  • Lung Neoplasms (etiology, physiopathology)
  • Mice
  • Neoplasms, Radiation-Induced (etiology, physiopathology)
  • Radiation Dosage
  • Radon (adverse effects)
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: